| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/07/2005 | US20050074470 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 04/07/2005 | US20050074463 Therapeutic vaccination method, mutated peptides of hiv reverse transciptase and their use for vaccination and diagnostic purposes |
| 04/07/2005 | US20050074457 Simplified, high throughput screening for identification of heat shock protein 90 ligands selective for high affinity form |
| 04/07/2005 | US20050074450 Compositions comprising neisseria meningitidis antigens from serogroups b and c |
| 04/07/2005 | US20050074441 probiotics having immunomodulatory activity, used for prophylaxis gastrointestinal disorders such as inflammatory bowel disease or irritable bowel syndrome |
| 04/07/2005 | US20050074429 Optimal compositions and methods thereof for treating HCV infections |
| 04/07/2005 | US20050074427 IL-17 like molecules and uses thereof |
| 04/07/2005 | US20050074416 lactic bacteria strain dairy in origin, may administer in an edible composition, adheres to tooth surface and produces growth inhibition factor |
| 04/07/2005 | DE10341579A1 Verwendung von Extrakten aus Gentiana lutea als antimikrobiell wirkendes Mittel Use of extracts from Gentiana lutea as antimicrobial agent |
| 04/07/2005 | CA2540701A1 Proteins expressed in nk cells |
| 04/07/2005 | CA2540243A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 04/07/2005 | CA2540242A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 04/07/2005 | CA2540239A1 Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors |
| 04/07/2005 | CA2540104A1 Water soluble nanoparticles comprising inclusion complexes |
| 04/07/2005 | CA2540083A1 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 04/07/2005 | CA2540021A1 Hcv inhibitors and methods of using them |
| 04/07/2005 | CA2533873A1 Method for attenuating virulence of microbial pathogens and for inhibiting microbial biofilm formation |
| 04/06/2005 | EP1520860A2 Recombinant protein PilC, method for its production and use thereof |
| 04/06/2005 | EP1520584A1 Composition for the activation of the immune system |
| 04/06/2005 | EP1520021A2 Antisense modulation of lrh1 expression |
| 04/06/2005 | EP1520015A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/06/2005 | EP1519961A1 Low molecular weight oversulfated polysaccharide |
| 04/06/2005 | EP1519960A2 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 04/06/2005 | EP1519952A1 Use of aspartic proteases in cosmetics and therapeutics |
| 04/06/2005 | EP1519951A2 Cationic linear peptides having antibacterial and/or antifungal properties |
| 04/06/2005 | EP1519939A2 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 04/06/2005 | EP1519924A1 Difluorothioacetamides of oxazolidinones as antibacterial agents |
| 04/06/2005 | EP1519922A1 Di-aryl-substituted ethane pyridone pde4 inhibitors |
| 04/06/2005 | EP1519750A2 Oxygenating agents for enhancing host responses to microbial infections |
| 04/06/2005 | EP1519745A1 Method to enhance an immune response of nucleic acid vaccination |
| 04/06/2005 | EP1519735A2 Assays and implements for determining and modulating hsp90 binding activity |
| 04/06/2005 | EP1519722A1 Glycoloyl-substituted oxazolidinone-derivatives as antibacterial agents |
| 04/06/2005 | EP1519719A1 Methods for the treatment of sinusitis |
| 04/06/2005 | EP1307455B1 Inhibitors of alpha-l beta-2 mediated cell adhesion |
| 04/06/2005 | EP1239840B1 Antiviral medication |
| 04/06/2005 | EP1117769B1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/06/2005 | EP1113809B1 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
| 04/06/2005 | EP1090012A4 Inhibitors of prenyl-protein transferase |
| 04/06/2005 | EP1090011A4 Inhibitors of prenyl-protein transferase |
| 04/06/2005 | EP1002093B1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 04/06/2005 | EP0912521B1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 04/06/2005 | EP0824594B1 Improved methods for transfecting t cells |
| 04/06/2005 | CN1604941A Anti-bacterial composite particles and anti-bacterial resin composition |
| 04/06/2005 | CN1604910A Affinity enhancement agents |
| 04/06/2005 | CN1604909A Cyclic peptides as g-protein-coupled receptor antagonists |
| 04/06/2005 | CN1604908A Process for the preparation of echinocandin derivatives |
| 04/06/2005 | CN1604906A Antisense antiviral agent and method for treating ssRNA viral infection |
| 04/06/2005 | CN1604901A Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/06/2005 | CN1604890A 取代的环己烷衍生物 Substituted cyclohexane derivatives |
| 04/06/2005 | CN1604803A Combination of cytochome p450 dependent protease inhibitors |
| 04/06/2005 | CN1604795A Combination motif immune stimulatory oligonucleotides with improved activity |
| 04/06/2005 | CN1604793A Methods of treatment and formulations of cephalosporin |
| 04/06/2005 | CN1604790A Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 04/06/2005 | CN1604787A Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI) |
| 04/06/2005 | CN1604786A Anti-hsv agent for inhibiting replication of HSV-1 and HSV-2 and method of producing a substance having anti-HSV activity |
| 04/06/2005 | CN1604782A Stabilized brivudine topical formulations |
| 04/06/2005 | CN1604779A Novel methods of treating local fungal and bacterial infections |
| 04/06/2005 | CN1604776A 4-4-alkoxy-3-hydroxyphenyl-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 04/06/2005 | CN1604741A Adhesion inhibition of moulds |
| 04/06/2005 | CN1603346A Protein, products containing same, and their use in diagnosis, treatment and /or prevention of SARS related disease |
| 04/06/2005 | CN1603327A New process for the preparation of vinyl pyrrolidinone cephalosporine derivatives |
| 04/06/2005 | CN1602962A Complete virus gene engineering vaccine of aftosa and its preparation method |
| 04/06/2005 | CN1602958A A and O type gene engineering bivalent polypeptide vaccine of livestock foot-and-mouth disease virus and its preparation process |
| 04/06/2005 | CN1602957A Hybrid yeast AIDS vaccine |
| 04/06/2005 | CN1602956A Deactivated BCG for treating disease |
| 04/06/2005 | CN1602955A Biological bacteria inhibitor |
| 04/06/2005 | CN1602954A Pharmaceutical composition with liver cell protecting function |
| 04/06/2005 | CN1602936A Application of golden buckwheat rhizome in the preparing process of medicine for treating respiratory syncytial virus infected disease |
| 04/06/2005 | CN1602933A Capsule for treating tuberculosis and its preparing process |
| 04/06/2005 | CN1602917A 'Shengmai' formulation and its preparation process |
| 04/06/2005 | CN1602900A Pharmaceutical composition for treating diarrhea, dysentery and eruptive disease |
| 04/06/2005 | CN1602889A Preparation method of clindamycin phosphate powder injection |
| 04/06/2005 | CN1602888A Azithromycin enteric casing preparation and its preparing process |
| 04/06/2005 | CN1602887A Erythromycin ethylsuccinate for injection and its preparation process and application |
| 04/06/2005 | CN1602886A Pharmaceutical compositions and its application |
| 04/06/2005 | CN1602872A Antituberculosis pharmaceutical composition |
| 04/06/2005 | CN1602871A Preparation process of antifungal itraconazole containing freeze dried powder injection and transfusion |
| 04/06/2005 | CN1602864A Vaginal effervescent tablet of fibrauretine and its preparation method |
| 04/06/2005 | CN1602862A Application of leflunomide in the preparation process of anti SARS virus medicine |
| 04/06/2005 | CN1602861A Buccal tablet for treating oral anaerobe infection disease and its manufacturing method |
| 04/06/2005 | CN1602858A Arteannuin preparation for treating gynecopathy |
| 04/06/2005 | CN1602853A Active constituent of traditional Chinese medicine capable of inhibiting SARS coronavirus infection and its bioactivity measuring method |
| 04/06/2005 | CN1602852A Sodium houttuyfonate injection and its preparation method |
| 04/06/2005 | CN1602841A Immuno-modulatory agents administration form for whole body or local immunity disorder |
| 04/06/2005 | CN1195854C Porcine circovirus recombinant poxvirus vaccine |
| 04/06/2005 | CN1195775C Glucoprotein having inhibitory activity to pyroric spirillar colonization |
| 04/06/2005 | CN1195774C HEV antigenic peptide and its method |
| 04/06/2005 | CN1195770C Preparation of d4T from 5-methyl uridine |
| 04/06/2005 | CN1195759C Process for preparation of benzoxazine derivatives and intermediates therefor |
| 04/06/2005 | CN1195758C Optical pure analog of camptothecine |
| 04/06/2005 | CN1195757C Optically pure camptothecin analogues |
| 04/06/2005 | CN1195745C Antiviral macrocyclic compounds |
| 04/06/2005 | CN1195737C HIV proteinase inhibitor |
| 04/06/2005 | CN1195548C Stable mitoxantron solutions |
| 04/06/2005 | CN1195545C Vaginal suppository vaccine for urogenital infections |
| 04/06/2005 | CN1195541C Medicine composition for treating chronic hepatitis B |
| 04/06/2005 | CN1195532C Oral capsule for treating condyloma acuminata |
| 04/06/2005 | CN1195531C Chinese medicinal herbs prescription for treating hepatitis B |
| 04/06/2005 | CN1195527C Hydroypropyl-beta-cyclodextrin inclusion compound of Rhizoma Zedoariae oil and preparation and preparing method |
| 04/06/2005 | CN1195526C Medicinal products containing antimer pure beta-D-dioxypentacyclic nucleoside |